Draft NIST Guidance Highlights Supply Chain Fundamentals as Key Practices in Cyber Supply Chain Risk Management
Client Alert | 1 min read | 02.21.20
Last week, the National Institute of Standards and Technology (NIST) published the draft NISTIR 8276 “Key Practices in Cyber Supply Chain Risk Management” providing Key Practices and related recommendations for monitoring, controlling, and understanding how to conduct cyber – supply chain risk management (C-SCRM). The Eight Key Practices are general and apply equally, in practice, to both traditional supply chain management and C-SCRM, including:
- Integrating SCRM across the organization,
- Understanding the organization’s supply chain, and
- Assessing and monitoring SCRM throughout the supplier relationship.
Specific guidance includes, among others:
- Increasing Board involvement in C-SCRM;
- Understanding the cyber relationship with suppliers, including whether they process critical data; and
- Using third-party assessments to evaluate suppliers.
The guidance should serve to remind organizations of the need to know their supply chain well and to have a purposeful approach to its management. Organizations have an opportunity to comment on this draft guidance until March 4, 2020.
Contacts

Partner and Crowell Global Advisors Senior Director
- Washington, D.C.
- D | +1.202.624.2698
- Washington, D.C. (CGA)
- D | +1 202.624.2500
Insights
Client Alert | 4 min read | 09.16.26
CMS Offers Guidance as Scrutiny Rises Over ABA Therapy in Medicaid
Between 2021 and 2025, Medicaid spending on ABA therapy grew six times faster than the number of children who received services, making it one of the fastest-growing areas of Medicaid expenditure, according to CMS. On August 4, 2026, CMS released a toolkit to help state Medicaid and CHIP agencies strengthen their programs and limit fraud, waste, and abuse tied to increased demand for ABA therapy. In 2025, Medicaid spent about $10 billion on ABA and related therapy services for children with ASD — a dramatic increase from the $2 billion spent in 2021.
Client Alert | 4 min read | 09.15.26
GAO Indicates Reasonable Conflict of Interest Investigation Must Include Inquiry of Involved Firm
Client Alert | 3 min read | 09.15.26
Client Alert | 7 min read | 09.14.26
AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development

